Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mental health: a global focus 2018

Journal article

Tomlinson A. et al, (2018), The Lancet Psychiatry, 5, 617 - 617

DO NMDAR ANTIBODIES CAUSE SCHIZOPHRENIA?

Conference paper

Lennox B., (2018), SCHIZOPHRENIA BULLETIN, 44, S60 - S60

Influence of prebiotic intake on olanzapine-mediated weight gain, central receptors, peripheral biomarkers, and gut microbiota

Conference paper

Kaon A. et al, (2018), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 28, S14 - S15

Neuroimmunology 2017: making progress over 20 years

Journal article

Al-Diwani AAJ. and Lennox BR., (2018), LANCET PSYCHIATRY, 5, 9 - 10

Neuroimmunology 2017: making progress over 20 years.

Journal article

Al-Diwani AA. and Lennox BR., (2018), Lancet Psychiatry, 5, 9 - 10

Bullying victimisation and psychosis: The interdependence and independence of risk trajectories

Journal article

Catone G. et al, (2017), BJPsych Advances, 23, 397 - 406

Psychosis: an autoimmune disease?

Journal article

Al-Diwani AAJ. et al, (2017), Immunology, 152, 388 - 401

NMDAR antibodies in first episode psychosis: conclusions too inflammatory given results? - Authors' reply.

Journal article

Lee M-M. et al, (2017), The lancet. Psychiatry, 4, 356 - 357

Serum neuronal cell-surface antibodies in first-episode psychosis-Authors' reply.

Other

Lennox BR. et al, (2017), Lancet Psychiatry, 4, 187 - 188

Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Journal article

Al-Diwani A. et al, (2017), Front Psychiatry, 8

Load More +